Renal functional reserve in kidney and heart transplant recipients

Journal of the American Society of Nephrology

Volumn 7, Issue 8, 1996, Pages 1145-1152

  Ader, Jean Louis ^a   Tack, Ivan ^a   Durand, Dominique ^a   Tran Van, Tuan ^a   Rostaing, Lionel ^a   Suc, Jean Michel ^a  

^a CHU RANGUEIL   (France)

Author keywords

Amino acid infusion; Cyclosporine; Renal hemodynamics; Renal transplantation cardiac transplantation

Indexed keywords

AMINO ACID; AZATHIOPRINE; CYCLOSPORIN; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HEART DENERVATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY VASCULAR RESISTANCE; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SYMPATHETIC INNERVATION;

EID: 0030377729     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. The Canadian Multicentre Transplant Study Group: A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1986;314:1219-1225.
2. Lewis RM, Janney RP, Golden DL, et al.: Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy: Five year follow-up. Transplantation 1989;47:266-272.
3. Slomowitz LA, Wilkinson A, Hawkins R, Danovitch G: Evaluation of kidney function in renal transplant patients receiving long-term cyclosporine. Am J Kidney Dis 1990;15:530-534.
4. Almond PS, Gillingham KJ, Sibley R, et al.: Renal transplant function after ten years of cyclosporine. Transplantation 1992;53:316-323.
5. Lewis R, Podbielski J, Sprayberry S, et al.: Stability of renal allograft glomerular filtration rate associated with long-term use of cyclosporine A. Transplantation 1993; 55:1014-1017.
6. Burke JF Jr, Pirsch JD, Ramos EL, et al.: Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994;331:358-363.
7. Beveridge T, Calne RY (for the European Multicentre Group): Cyclosporine (Sandimmun®) in cadaveric renal transplantation: Ten-year follow-up of a multicenter trial. Transplantation 1995;59:1568-1570.
8. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M: Cyclosporine-associated chronic nephropathy. N Engl J Med 1984;311:699-705.
9. Greenberg A, Egel JW, Thompson ME, et al.: Early and late forms of cyclosporine nephrotoxicity: Studies in cardiac transplant recipients. Am J Kidney Dis 1987;9: 12-22.
10. Myers BD, Sibley R, Newton L, et al.: The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988;33:590-600.
11. Greenberg A, Thompson ME, Griffith BJ, et al.: Cyclosporine nephrotoxicity in cardiac allograft patients: A seven-year follow-up. Transplantation 1990;50:589-593.
12. Bertani T, Ferrazzi P, Schieppati A, et al.: Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991;40:243-250.
13. Waser M, Maggiorini M, Binswanger U, et al.: Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. J Heart Lung Transplant 1993;12:846-850.
14. Zietse R, Balk AH, Dorpel MA, Meeter K, Bos E, Weimar W: Time course of the decline in renal function in cyclosporine-treated heart transplant recipients. Am J Nephrol 1994;14:1-5.
15. Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ: Progressive renal insufficiency following cardiac transplantation: Cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995;26:193-201.
16. Lewis RM, Van Buren CT, Radovancevic B, et al.: Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: Serial renal function in heart and kidney transplant recipients. J Heart Lung Transplant 1991;10:63-70.
17. Bosch JP, Lew S, Glabman S, Lauer A: Renal hemodynamic changes in humans: Response to protein loading in normal and diseased kidneys. Am J Med 1986;81: 809-815.
18. Hostetter TH: Human renal response to a meat meal. Am J Physiol 1986;250:F613-F618.
19. Ter Wee PM, Rosman JB, Van Der Geest S, Sluiter WJ, Donker AJM: Renal hemodynamics during separate and combined infusion of amino acids and dopamine. Kidney Int 1986;29:870-874.
20. Woods LL, Mizelle HL, Montani JP, Hall JE: Mechanisms controlling renal hemodynamics and electrolyte excretion during amino acids. Am J Physiol 1986;251: F303-F312.
21. Memoli B, Libetta C, Sabbatini M, et al.: Renal functional reserve: Its significance in normal and salt depletion conditions. Kidney Int 1991;40:1134-1140.
22. Murray BM, Paller MS, Ferris TF: Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985;28:767-774.
23. Thomson SC, Tucker BJ, Gabbai F, Blantz RC: Functional effects on glomerular hemodynamics of short-term chronic cyclosporine in male rats. J Clin Invest 1989;83: 960-969.
24. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-659.
25. Cairns HS, Raval U, Neild GH: Failure of cyclosporine-treated renal allograft recipients to increase glomerular filtration rate following an amino acid infusion. Transplantation 1988;46:79-82.
26. Rondeau E, Paillard F, Peraldi MN, et al.: Role of the renin-angiotensin system on the renal functional reserve in renal transplant recipients. Kidney Int 1993;44:165-172.
27. Ader JL, Tack I, Lloveras JJ, et al.: Renal functional reserve in cyclosporine-treated recipients of kidney transplant. Kidney Int 1994;45:1657-1667.
28. Chagnac A, Zevin D, Weinstein T, et al.: Effect of nifedipine on the renal functional reserve in cyclosporine-treated renal-transplant recipients. Nephron 1995; 70:207-210.
29. Hansen JM, Løkkegaard H, Høy CE, Fogh-Andersen N, Olsen NV, Strandgaard S: No effect of dietary fish oil on renal hemodynamics, tubular function, and renal functional reserve in long-term renal transplant recipients. J Am Soc Nephrol 1995;5:1434-1440.
30. MacNally PG, Feehally J: Pathophysiology of cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant 1992;7:791-804.
31. Baylis C, Fredericks M, Wilson C, Munger K, Collins R: Renal vasodilatory response to intravenous glycine in the aging rat kidney. Am J Kidney Dis 1990;15:244-251.
32. Böhler J, Glöer D, Reetze-Bonorden P, Keller E, Schollmeyer PJ: Renal functional reserve in elderly patients. Clin Nephrol 1993;39:145-150.
33. Fliser D, Zeier M, Nowack R, Ritz E: Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 1993;3:1371-1377.
34. De Santo NG, Anastasio P, Coppola S, Barba G, Jadanza A, Capasso G: Age-related changes in renal reserve and renal tubular function in healthy humans. Child Nephrol Urol 1991;11:33-40.
35. Perico N, Ruggenenti P, Gaspari F, et al.: Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992;54:56-60.
36. Moss NG, Powell SL, Falk RJ: Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985;82:8222-8226.
37. Murray BM, Paller MS: Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats. Clin Nephrol 1986;25[Suppl 1]:S37-S39.
38. Lyson T, McMullan DM, Ermel LAD, Morgan BJ, Victor RG: Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats. Hypertension 1994;23:667-675.
39. Scherrer U, Vissing SF, Morgan BJ, et al.: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-699.
40. Myers BD, Peterson C, Molina C, et al.: Role of cardiac atria in the human renal response to changing plasma volume. Am J Physiol 1988;254:F562-F573.
41. Feehally J, Walls J, Mistry N, et al.: Does nifedipine ameliorate cyclosporin A nephrotoxicity? Br Med J 1987; 295:310.
42. Palmer BF, Dawidson I, Sagalowsky A, Sandor Z, Lu CY: Improved outcome of cadaveric renal transplantation due to calcium channel blockers. Transplantation 1991; 4:640-645.
43. Gonwa TA, Mai ML, Pilcher JB, et al.: Stability of long-term renal function in heart transplant patients treated with induction therapy and low-dose cyclosporine. J Heart Lung Transplant 1992;11:926-928.
44. Ruggenenti P, Perico N, Amuchastegui CS, Ferrazzi P, Mamprin F, Remuzzi G: Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine. Am J Kidney Dis 1994; 24:549-553.